Aurora Plans Hostile Takeover of CanniMed CanniMed Therapeutics Inc. (TSX:CMED) rejected a merger offer from Aurora Cannabis Inc. (TSX:ACB) The move set in motion a planned hostile takeover of the Canadian cannabis company. It follows CanniMed’s announcement of the acquisition of Newstrike Resources Ltd. (CVE:HIP) for CAD $248 million. Aurora will go straight to CanniMed shareholders. They will argue a merger creates more value and an “expanded international presence.”
Cannabix Technologies Inc.’s (CSE:BLO) (OTC PINK:BLOZF) recent patent filings for a cannabis-based Ignition Interlock Device have investors salivating. There is a lot of financial potential in the new technology. Stock prices rose almost 50 percent on the news in early November, from $0.45 a share to $0.70 a share. Over 1 million shares traded during that time.
Paul Masso, a graduate student in Drexel University’s M.S. in Professional Studies with a concentration in homeland security management, understood that the technicalities of homeland security were only the beginning of a fundamental education in the field. He knew that, more importantly perhaps, he needed to learn, in his own words, “The importance of effective communication among coworkers, as well as upper management, to provide the wanted outcome.”